Cox models for OS, DFS, NRM, and relapse
| Variable . | HR . | 95% CI . | P . |
|---|---|---|---|
| OS | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.50 | 1.05-2.14 | .028 |
| ≥38 vs ≤29.5 | 1.42 | 1.02-2.06 | .049 |
| Age, y | |||
| ≥55 vs <55 | 1.94 | 1.45-2.59 | <.001 |
| Disease risk | |||
| Intermediate vs low | 1.39 | 0.99-1.95 | .056 |
| High vs low | 1.68 | 1.10-2.58 | .018 |
| Year of transplantation | |||
| 2010-2014 vs 2003-2009 | 0.67 | 0.46-0.96 | .029 |
| 2015-2017 vs 2003-2009 | 0.56 | 0.35-0.88 | .011 |
| DFS | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.36 | 0.99-1.87 | .055 |
| ≥38 vs ≤29.5 | 1.31 | 0.95-1.80 | .102 |
| Age, y | |||
| ≥55 vs <55 | 1.67 | 1.28-2.17 | <.001 |
| Disease risk | |||
| High vs low | 1.74 | 1.21-2.49 | .003 |
| TRM | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.91 | 1.14-3.21 | .014 |
| ≥38 vs ≤29.5 | 1.80 | 1.07-3.04 | .028 |
| Age, y | |||
| ≥55 vs <55 | 1.72 | 1.15-2.56 | .008 |
| Relapse | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.05 | 0.70-1.57 | .820 |
| ≥38 vs ≤29.5 | 0.99 | 0.66-1.49 | .950 |
| Diagnosis | |||
| AML vs other | 1.90 | 1.21-2.98 | .005 |
| ALL vs other | 2.33 | 1.31-4.13 | .004 |
| Disease risk | |||
| High vs low | 2.13 | 1.38-3.27 | <.001 |
| Intensity | |||
| Myeloablative vs nonmyeloablative/RIC | 0.58 | 0.40-0.84 | .004 |
| Variable . | HR . | 95% CI . | P . |
|---|---|---|---|
| OS | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.50 | 1.05-2.14 | .028 |
| ≥38 vs ≤29.5 | 1.42 | 1.02-2.06 | .049 |
| Age, y | |||
| ≥55 vs <55 | 1.94 | 1.45-2.59 | <.001 |
| Disease risk | |||
| Intermediate vs low | 1.39 | 0.99-1.95 | .056 |
| High vs low | 1.68 | 1.10-2.58 | .018 |
| Year of transplantation | |||
| 2010-2014 vs 2003-2009 | 0.67 | 0.46-0.96 | .029 |
| 2015-2017 vs 2003-2009 | 0.56 | 0.35-0.88 | .011 |
| DFS | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.36 | 0.99-1.87 | .055 |
| ≥38 vs ≤29.5 | 1.31 | 0.95-1.80 | .102 |
| Age, y | |||
| ≥55 vs <55 | 1.67 | 1.28-2.17 | <.001 |
| Disease risk | |||
| High vs low | 1.74 | 1.21-2.49 | .003 |
| TRM | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.91 | 1.14-3.21 | .014 |
| ≥38 vs ≤29.5 | 1.80 | 1.07-3.04 | .028 |
| Age, y | |||
| ≥55 vs <55 | 1.72 | 1.15-2.56 | .008 |
| Relapse | |||
| TERS score | |||
| 30-37.5 vs ≤29.5 | 1.05 | 0.70-1.57 | .820 |
| ≥38 vs ≤29.5 | 0.99 | 0.66-1.49 | .950 |
| Diagnosis | |||
| AML vs other | 1.90 | 1.21-2.98 | .005 |
| ALL vs other | 2.33 | 1.31-4.13 | .004 |
| Disease risk | |||
| High vs low | 2.13 | 1.38-3.27 | <.001 |
| Intensity | |||
| Myeloablative vs nonmyeloablative/RIC | 0.58 | 0.40-0.84 | .004 |